Latest Articles
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron - Nature.com
Targeting the splicing factor SNRPB inhibits endometrial cancer progression by retaining the POLD1 intron Nature.com
Published: Feb. 5, 2025, 11:37 a.m.
The Elon Musk effect is in full swing / shein targeted by a CE / Outbrain investigation, now call me a tank! - Businesslife.co
The Elon Musk effect is in full swing / shein targeted by a CE / Outbrain investigation, now call me a tank! Businesslife.co
Published: Feb. 4, 2025, 10:35 p.m.
Endometriosis affects 1m+ in Australia. This AI platform is targeting women’s health - Forbes Australia
Endometriosis affects 1m+ in Australia. This AI platform is targeting women’s health Forbes Australia
Published: Feb. 4, 2025, 8:24 a.m.
Endometriosis affects 1m+ Australians. Now there’s an AI platform targeting women’s health - Forbes Australia
Endometriosis affects 1m+ Australians. Now there’s an AI platform targeting women’s health Forbes Australia
Published: Feb. 4, 2025, 8:24 a.m.
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 - Frontiers
Engineered Exosomes Restore miR-508-5p Expression in Uterine Corpus Endometrial Carcinoma and Reduce Tumor Progression and Metastasis by Targeting DLL3 Frontiers
Published: Feb. 3, 2025, 2:27 p.m.
Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer - OncLive
Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer OncLive
Published: Feb. 1, 2025, 12:11 a.m.
Retrospective Data Highlight FRα and B7-H4 as Potential ADC Targets in Endometrial Cancer - OncLive
Retrospective Data Highlight FRα and B7-H4 as Potential ADC Targets in Endometrial Cancer OncLive
Published: Feb. 1, 2025, 12:11 a.m.
Health Spotlight | Ultrasound targets chronic pain and depression - MSN
Health Spotlight | Ultrasound targets chronic pain and depression MSN
Published: Jan. 21, 2025, 11:53 p.m.
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis - BSA bureau
Hong Kong unveils novel therapeutic targets and drug repurposing opportunities for endometriosis BSA bureau
Published: Jan. 14, 2025, 2:14 p.m.
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma - Nature.com
Bioinformatics approaches to multi-omics analysis of the potential of CDKN2A as a biomarker and therapeutic target for uterine corpus endometrial carcinoma Nature.com
Published: Jan. 6, 2025, 7:50 a.m.
Link copied to clipboard!